Biogen Inc. buy Royal Bank of Canada
Start price
08.10.25
/
50%
€130.40
Target price
08.10.26
€186.64
Performance (%)
-3.30%
Price
20:41
€126.10
Summary
This prediction is currently active. With a performance of -3.30%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 08.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | 0.719% |
| iShares Core DAX® | -0.420% |
| iShares Nasdaq 100 | 0.946% |
| iShares Nikkei 225® | 5.808% |
| iShares S&P 500 | 0.608% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $219.00 to $217.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat